Heme oxygenase-1 mediates cytoprotection against nitric oxide-induced cytotoxicity via the cGMP pathway in human pulp cells

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Dec;102(6):803-8. doi: 10.1016/j.tripleo.2005.11.036. Epub 2006 May 11.

Abstract

Objective: This study examined the effects of exogenous nitric oxide (NO) on human pulp cells and the involvement of cyclic 3',5'-monophosphate (cGMP) in pulpal protection induced by heme oxygenase-1 (HO-1) against NO-induced cytotoxicity.

Study design: This study investigated cytotoxicity and HO-1 induction in pulp cells induced by the NO donor S-nitroso-N-acetyl-D,L-penicillamine (SNAP), by using Western blotting and a cell viability assay. It also investigated whether HO-1 contributes to the cytoprotective effect against the cytotoxicity caused by NO and the relationship between HO-1 and cGMP in the signaling pathway.

Results: S-nitroso-N-acetyl-D,L-penicillamine decreased cell viability, but increased HO-1 expression in a concentration- and time-dependent manner in human pulp cells. NO-induced cytotoxicity was inhibited in the presence of hemin (inducer of HO-1), whereas it was enhanced in the presence of zinc protoporphyrin IX (ZnPP IX, HO-1 inhibitor); therefore, the NO-induced cytotoxicity was correlated with HO-1 expression. Pretreatment with a membrane-permeable cGMP analog, 8-bromo-cGMP, restored cell death and enhanced the HO-1 protein expression induced by SNAP. By contrast, 1 mM SNAP inhibited guanylate cyclase in pulp cells pretreated with 1H-[1,2,4]oxadiazole[4,3-alpha]quinoxalin-1-one (ODQ), resulting in marked cytotoxicity.

Conclusion: These findings of a link between HO-1, regulated via the cGMP system and NO-induced cytotoxicity in human pulp cells, suggest a protective role for HO-1 in pulpal inflammation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blotting, Western
  • Cell Survival / drug effects
  • Cells, Cultured
  • Cyclic GMP / metabolism*
  • Cytoprotection / physiology
  • Dental Pulp / cytology
  • Dental Pulp / enzymology*
  • Enzyme Induction
  • Enzyme Inhibitors / pharmacology
  • Guanylate Cyclase / antagonists & inhibitors
  • Heme Oxygenase-1 / antagonists & inhibitors
  • Heme Oxygenase-1 / biosynthesis
  • Heme Oxygenase-1 / physiology*
  • Hemin / pharmacology
  • Humans
  • Nitric Oxide / antagonists & inhibitors
  • Nitric Oxide / toxicity*
  • Nitric Oxide Donors / pharmacology
  • Oxadiazoles / pharmacology
  • Oxidative Stress / drug effects*
  • Penicillamine / analogs & derivatives
  • Penicillamine / pharmacology
  • Protoporphyrins / pharmacology
  • Quinoxalines / pharmacology

Substances

  • 1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one
  • Enzyme Inhibitors
  • Nitric Oxide Donors
  • Oxadiazoles
  • Protoporphyrins
  • Quinoxalines
  • S-nitro-N-acetylpenicillamine
  • zinc protoporphyrin
  • Nitric Oxide
  • Hemin
  • Heme Oxygenase-1
  • Guanylate Cyclase
  • Penicillamine
  • Cyclic GMP